TOKYO (Reuters) – Daiichi Sankyo Co is in discussions with AstraZeneca Plc on developing supplies of a vaccine for the coronavirus in Japan, the Japanese company said on Friday.
In a statement, Daiichi Sankyo said it would receive stock solution from AstraZeneca for the domestic development.
(Reporting by Rocky Swift)
